Sodium chloride 0.9%
Ampoule 3ml, 5ml, 10ml

Multi dose ophthalmic

Topical treatment of dry eye, eye irritation, eye pain...
Topical treatment of symptoms of nasal congestion, runny nose.
Clean the wound and scratches.
Used for infants.
Cleaning the eyes, nose and navel children daily
Mark tongue for children.

The usual dose is 1 or 2 drops placed in each eye when  needed

Polyethylene glycol 400 4mg/ml; Propylene glycol 3 mg/ml
Ampoule 2ml, 3ml, 5ml, 10ml

Multi dose ophthalmic

Lubricate for eye.

Relief of dry eyes and eye irritation associated with deficient tear production.

Usually, instill 1 - 2 drops a time to the eye 5-6 times daily. The dosage may be adjusted according to the patient's symptoms.

Atropine sufate 0.01%

Single-dose ophthalmic

Reduce and control myopia process.

Shake the ampoule well before use, 1 drop into each eye.

Use 1 time a day before going to sleep.

Ketotifen (as ketotifen fumarate) 0.5mg/ml
Ampoule 0.4ml, 1ml

Single-dose ophthalmic

Acute and chronic conjunctivitis and keratoconjunctivitis of an allergic nature (spring, atopic and others).

Remove contact lenses before application and wait at least 15 minutes before reapplying them.

The bleaching action against soft contact lenses is known.

Keep the medicine out of reach of children.

Dosage

1 drop in the conjunctival sac 2 or more times per day according to medical prescription.

Method of use

To open, press the closing cap and at the same time unscrew it. After use, tighten completely.

Ketotifen (as ketotifen fumarate) 0.5mg/ml
Ampoule 3ml, 5ml, 10ml

Eye drops solution

Acute and chronic conjunctivitis and keratoconjunctivitis of an allergic nature (spring, atopic and others).

1 drop in the conjunctival sac 2 or more times a day, according to medical prescription.

Levofloxacin (as Levofloxacin hemihydrate) 5 mg/ml
Ampoule 3ml, 5ml, 10ml

Eye drops solution

Topical treatment of bacterial external ocular infections in patients
≥1 year of age caused by levofloxacin susceptible microorganisms

Posology

For all patients instil one to two drops in the affected eye(s) every two hours up to 8 times per day while awake for the first two days and then four times daily on days 3 through 5.

If different topical ocular medications are used concomitantly, at least a 15-minute interval is required between instillations.

The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection. The usual treatment duration is 5 days.

Safety and efficacy in the treatment of corneal ulcer and ophthalmia neonatorum has not been established.

Use in the Elderly

No adjustment of dosage is required.

Paediatric population

The posology is the same in adults and children aged ≥1 year.

The safety and efficacy of Levofloxacin in children aged ≥1 year have been established.

Levofloxacin is not recommended for use in children below age 1 year due to a lack of data on safety and efficacy.

The safety and efficacy of Levofloxacin in children aged < 1 year have not yet been established.

No data are available.

Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml
 

Single-dose ophthalmic

Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.

Adults:

One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.

Use in the Elderly:

Clinical studies have indicated dosage modifications are not required for use in the elderly.

Paediatric population:

Drug may be used in children 2 years of age and older at the same dose as in adults.

Tobramycin (asTobramycin sulfate) 3 mg/ml
Dexamethasone phosphate (as
dexamethasone sodium phosphate) 1 mg/ml
Ampoule 3ml, 5ml, 10ml

Eye drops solution

Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.

• Adults:

  One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.

  Use in the Elderly:

  Clinical studies have indicated dosage modifications are not required for use in the elderly.

  Paediatric population:

  TOBRAMESON may be used in children 2 years of age and older at the same dose as in adults.

  The safety and efficacy in children younger than 2 years of age have not been established, and no data is available.

  Use in hepatic and renal impairment:

  TOBRAMESON has not been studied in these patient populations

  Shake the bottle well before use. To prevent contamination of the dropper tip and suspension, care should be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use. After cap is removed, if tamper evident snap collar is loose, remove before using product.

  Gently closing the eyelid (s) and nasolacrimal occlusion for at least 1 minute after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.

  In case of concomitant therapy with other topical ophthalmic medicinal products, an interval of 5 minutes should be allowed between successive applications.

  Eye ointments should be administered last.

Levofloxacin (as Levofloxacin hemihydrate) 5mg/ml; Dexamethasone phosphate (as Dexamethasone sodium phosphate) 1mg/ml
Ampoule 3ml, 5ml, 10 ml

Eye drops solution

Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation associated with infection.

- Day 1 and 2: 1-2 drops/time into eyes each 2 hours, 8 times/day.

- From day 3 to 7: 1-2 drops/time each 4 hours, 4 times/day.

- The number of drops should be reduced gradually when there are improvements in clinical signs. Should not stop treatment too soon.

 To avoid contamination of the tip of the vial and drug solution, do not let the tip touch the eyelid, the area around the eye or any object.

- After opening the lid, the first drop should be removed before each use.

Moxifloxacine (as moxifloxacin hydrochloride) 5 mg/ml Dexamethasone phosphate (as dexamethasone sodium phosphate) 1 mg/ml
Ampoule 0.4ml, 1ml

Single-dose ophthalmic

Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation
associated with infection.

- Prevention of inflammation and infection after eye surgery:

Medication into the eye surgery begins 1 day before surgery and lasts for another 15 days after surgery

- Cataract surgery:

1 drop / time x 4 times / day, drops immediately after surgery

- LASIK refractive surgery:

1 drop / time x 4 times / day, instill the medicine within 15 minutes after surgery.

- Eye infections caused by susceptible bacteria:

1 drop / time x 4 times / day, within 7 days or as directed by your doctor.

Moxifloxacine (as moxifloxacin hydrochloride) 5 mg/ml

Dexamethasone phosphate (as dexamethasone sodium phosphate) 1 mg/ml
Ampoule 2ml, 3ml, 5ml, 8ml, 10ml

Eye drops solution

Indicated for:
+ Steroid-responsive inflammatory ocular conditions (for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists)
+ Post-operative inflammation and any other ocular inflammation
associated with infection.

To prevent post-surgery ocular inflammation and infection, instill 1 drop 4 times per day in the eye to be operated, starting 1 day before the surgery and during 15 days after the surgery. In patients submitted to cataract surgery, instill the solution immediately after the surgery. In patients submitted to refractive surgery by LASIK, instill the solution within 15 minutes after the surgery.
In the ocular infections caused by susceptible organisms, instill 1 drop 4 times per day during 7 days, or as directed by the doctor.
Follow the doctor's instructions on the schedule, dose and duration of treatment. Do not discontinue treatment without consulting the doctor. Do not use outdated medicine. Observe the appearance of the medicine before using it.
To prevent contaminating the dropper tip and solution, care should be taken not to touch any surface with the dropper tip of the bottle.
FOR OCULAR USE ONLY. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use. If the patient is using other eye drop or eye ointment medicines, leave at least 5 minutes between each medicine. Eye ointments should be administered last.

Moxifloxacin (as Moxifloxacin hydrochloride) 5 mg/ml
Ampoule 0.4 ml, 1ml

Single-dose ophthalmic

Topical treatment of purulent bacterial conjunctivitis, caused by moxifloxacin susceptible strains

 For ocular use only. Not for injection. MOXIEYE, solution should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye.

 Use  in  adults  including  the  elderly  (≥  65 years)

The dose is one drop in the affected eye(s) 3 times a day.

The infection normally improves within 5 days and treatment should then be continued for a further 2­3 days. If no improvement  is observed within 5 days of initiating therapy, the diagnosis and/or treatment should be reconsidered.  The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological  course of infection.

 Paediatric  patients

No dosage adjustment is necessary.

 Use in hepatic and renal impairment  No dosage adjustment is necessary.

To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.

In order to prevent the drops from being absorbed via the nasal mucosa, particularly  in new­born infants or children, the nasolacrimal  ducts should be held closed for 2 to 3 minutes with the fingers after administering the drops. After cap is removed, if tamper evident snap collar is loose, remove before using the product.

If more than one topical ophthalmic  medicinal product is being used, the medicinal products must be administered at least 5 minutes apart. Eye ointments should be administered last.